BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2296388)

  • 1. Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy.
    DeAngelis LM; Yahalom J; Heinemann MH; Cirrincione C; Thaler HT; Krol G
    Neurology; 1990 Jan; 40(1):80-6. PubMed ID: 2296388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined modality therapy for primary CNS lymphoma.
    DeAngelis LM; Yahalom J; Thaler HT; Kher U
    J Clin Oncol; 1992 Apr; 10(4):635-43. PubMed ID: 1548527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
    DeAngelis LM; Seiferheld W; Schold SC; Fisher B; Schultz CJ;
    J Clin Oncol; 2002 Dec; 20(24):4643-8. PubMed ID: 12488408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma.
    Fisher B; Seiferheld W; Schultz C; DeAngelis L; Nelson D; Schold SC; Curran W; Mehta M
    J Neurooncol; 2005 Sep; 74(2):201-5. PubMed ID: 16193393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
    Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis.
    Chamberlain MC; Kormanik P; Glantz M
    Oncol Rep; 1998; 5(2):521-5. PubMed ID: 9468593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.
    Schultz C; Scott C; Sherman W; Donahue B; Fields J; Murray K; Fisher B; Abrams R; Meis-Kindblom J
    J Clin Oncol; 1996 Feb; 14(2):556-64. PubMed ID: 8636771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
    Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M;
    J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of primary central nervous system lymphoma with pre-irradiation methotrexate, cyclophosphamide, doxorubicin, vincristine, and dexamethasone (MCHOD).
    Glass J; Shustik C; Hochberg FH; Cher L; Gruber ML
    J Neurooncol; 1996 Dec; 30(3):257-65. PubMed ID: 8943101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS.
    Forsyth PA; Yahalom J; DeAngelis LM
    Neurology; 1994 Aug; 44(8):1473-9. PubMed ID: 8058152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up.
    Omuro AM; DeAngelis LM; Yahalom J; Abrey LE
    Neurology; 2005 Jan; 64(1):69-74. PubMed ID: 15642906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Chemotherapy and Radiotherapy for Primary CNS Lymphoma.
    Lee JE; Kim DY; Ahn YC; Lim DH; Huh SJ; Shin SS; Kim WS; Kang WK; Nam DH; Lee JI; Kim JH
    Cancer Res Treat; 2001 Oct; 33(5):398-403. PubMed ID: 26680814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
    Yamanaka R; Shinbo Y; Sano M; Homma J; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Morii K; Onda K; Tanaka R
    Leuk Lymphoma; 2007 Jun; 48(6):1119-26. PubMed ID: 17577775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06.
    Corn BW; Dolinskas C; Scott C; Donahue B; Schultz C; Nelson DF; Fisher B
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):299-303. PubMed ID: 10802352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary CNS lymphoma in immunocompetent patients from 1989 to 2001: a retrospective analysis of 164 cases uniformly diagnosed by stereotactic biopsy.
    Feuerhake F; Baumer C; Cyron D; Illerhaus G; Olschewski M; Tilgner J; Ostertag CB; Volk B
    Acta Neurochir (Wien); 2006 Aug; 148(8):831-8; discussion 838. PubMed ID: 16791439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate.
    Reni M; Ferreri AJ; Guha-Thakurta N; Blay JY; Dell'Oro S; Biron P; Hochberg FH
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):419-25. PubMed ID: 11567816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.